financetom
Business
financetom
/
Business
/
PetIQ Agrees to $1.5 Billion Go-Private Deal With Bansk Group; Shares Soar
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PetIQ Agrees to $1.5 Billion Go-Private Deal With Bansk Group; Shares Soar
Aug 7, 2024 12:44 PM

03:16 PM EDT, 08/07/2024 (MT Newswires) -- PetIQ ( PETQ ) has agreed to be acquired by private investment firm Bansk Group in an all-cash deal valued at about $1.5 billion, sending the pet wellness company's shares soaring.

Bansk Group will buy PetIQ ( PETQ ) for $31 per share, representing a roughly 51% premium to the company's Tuesday closing stock price, according to a Wednesday joint statement.

PetIQ ( PETQ ) shares were up nearly 48% in Wednesday late-afternoon trade.

"After a comprehensive assessment of the offer with the assistance of our outside advisers, the board has determined that this transaction represents an attractive outcome for PetIQ ( PETQ ) and our stockholders," PetIQ ( PETQ ) Chief Executive Cord Christensen said. "This transaction provides us with an incredible opportunity to continue to execute on our strategy of providing pet parents convenient access to affordable pet healthcare while accelerating many longer-term growth initiatives."

Once the deal closes, PetIQ's ( PETQ ) common stock will no longer be listed on the Nasdaq. The company will continue to be operated independently by its executive team, according to the statement.

"As longtime investors in the consumer health and wellness space, we believe PetIQ ( PETQ ) has developed a portfolio of uniquely differentiated brands in the very attractive pet health and wellness category," Bansk Group Chairman Bart Becht said.

The deal is expected to close in the fourth quarter, subject to PetIQ ( PETQ ) stockholder approval and other conditions.

Separately, PetIQ ( PETQ ) reported that its second-quarter adjusted earnings jumped to $0.70 a share from $0.46 a year earlier, while net sales rose 4.6% to $328.9 million. Analysts polled by Capital IQ were looking for $0.50 and $330.1 million, respectively.

The company said it has suspended its full-year financial guidance in the light of the Bansk Group deal.

Price: 30.43, Change: +9.86, Percent Change: +47.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Starlink experiencing degraded service, Musk says satellites under pressure
Starlink experiencing degraded service, Musk says satellites under pressure
May 11, 2024
(Reuters) - Starlink, the satellite unit of Elon Musk's SpaceX, is experiencing a degraded service, its website showed on Saturday, adding that the team is investigating the issue. Musk in a post on X earlier said that Starlink satellites were under a lot of pressure due to a geomagnetic solar storm, but were holding up so far. ...
Iraq launches oil and gas licensing round for 29 projects
Iraq launches oil and gas licensing round for 29 projects
May 11, 2024
BAGHDAD, May 11 (Reuters) - Iraq is holding an oil and gas licensing round for 29 projects in a bid to develop its huge gas reservoirs to help power the country and lure billions of dollars in investments. The exploration blocks are spread across 12 governorates in mostly central and southern Iraq and for the first time include an offshore...
Fresenius Medical sees up to 2% US dialysis growth by year-end
Fresenius Medical sees up to 2% US dialysis growth by year-end
May 11, 2024
FRANKFURT, May 11 (Reuters) - The number of kidney dialysis sessions provided by Fresenius Medical Care in its top market, the United States, could rise by as much as 2% by the end of the year, its CEO said, as the impact of the pandemic on patients fades. WHY IT'S IMPORTANT Fresenius Medical Care is the world's largest kidney dialysis...
SoftBank seen returning to loss in Q4 despite tech stock strength
SoftBank seen returning to loss in Q4 despite tech stock strength
May 11, 2024
(This May 10 story has been corrected to specify that Arm is a subsidiary, not a wholly owned subsidiary of SoftBank Group ( SFTBF ), in paragraph 3) By Anton Bridge TOKYO (Reuters) - Japanese technology investor SoftBank Group ( SFTBF ) is expected to slip back into the red when it reports earnings on Monday despite technology stocks including...
Copyright 2023-2026 - www.financetom.com All Rights Reserved